Onychomycosis Market Size, Share, Growth, and Industry Analysis, By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis, Others), By Application (Hospital Pharmacies, Retail Pharmacies, Others), Regional Insights and Forecast to 2035
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Onychomycosis Market Size 2019-2030
2.1.2 Onychomycosis Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Onychomycosis Segment by Type
2.2.1 Distal Subungual Onychomycosis
2.2.2 White Superficial Onychomycosis
2.2.3 Proximal Subungual Onychomycosis
2.2.4 Candida Onychomycosis
2.2.5 Others
2.3 Onychomycosis Market Size by Type
2.3.1 Onychomycosis Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Onychomycosis Market Size Market Share by Type (2019-2024)
2.4 Onychomycosis Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Others
2.5 Onychomycosis Market Size by Application
2.5.1 Onychomycosis Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Onychomycosis Market Size Market Share by Application (2019-2024)
3 Onychomycosis Market Size by Player
3.1 Onychomycosis Market Size Market Share by Players
3.1.1 Global Onychomycosis Revenue by Players (2019-2024)
3.1.2 Global Onychomycosis Revenue Market Share by Players (2019-2024)
3.2 Global Onychomycosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Onychomycosis by Regions
4.1 Onychomycosis Market Size by Regions (2019-2024)
4.2 Americas Onychomycosis Market Size Growth (2019-2024)
4.3 APAC Onychomycosis Market Size Growth (2019-2024)
4.4 Europe Onychomycosis Market Size Growth (2019-2024)
4.5 Middle East & Africa Onychomycosis Market Size Growth (2019-2024)
5 Americas
5.1 Americas Onychomycosis Market Size by Country (2019-2024)
5.2 Americas Onychomycosis Market Size by Type (2019-2024)
5.3 Americas Onychomycosis Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Onychomycosis Market Size by Region (2019-2024)
6.2 APAC Onychomycosis Market Size by Type (2019-2024)
6.3 APAC Onychomycosis Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Onychomycosis by Country (2019-2024)
7.2 Europe Onychomycosis Market Size by Type (2019-2024)
7.3 Europe Onychomycosis Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Onychomycosis by Region (2019-2024)
8.2 Middle East & Africa Onychomycosis Market Size by Type (2019-2024)
8.3 Middle East & Africa Onychomycosis Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Onychomycosis Market Forecast
10.1 Global Onychomycosis Forecast by Regions (2025-2030)
10.1.1 Global Onychomycosis Forecast by Regions (2025-2030)
10.1.2 Americas Onychomycosis Forecast
10.1.3 APAC Onychomycosis Forecast
10.1.4 Europe Onychomycosis Forecast
10.1.5 Middle East & Africa Onychomycosis Forecast
10.2 Americas Onychomycosis Forecast by Country (2025-2030)
10.2.1 United States Onychomycosis Market Forecast
10.2.2 Canada Onychomycosis Market Forecast
10.2.3 Mexico Onychomycosis Market Forecast
10.2.4 Brazil Onychomycosis Market Forecast
10.3 APAC Onychomycosis Forecast by Region (2025-2030)
10.3.1 China Onychomycosis Market Forecast
10.3.2 Japan Onychomycosis Market Forecast
10.3.3 Korea Onychomycosis Market Forecast
10.3.4 Southeast Asia Onychomycosis Market Forecast
10.3.5 India Onychomycosis Market Forecast
10.3.6 Australia Onychomycosis Market Forecast
10.4 Europe Onychomycosis Forecast by Country (2025-2030)
10.4.1 Germany Onychomycosis Market Forecast
10.4.2 France Onychomycosis Market Forecast
10.4.3 UK Onychomycosis Market Forecast
10.4.4 Italy Onychomycosis Market Forecast
10.4.5 Russia Onychomycosis Market Forecast
10.5 Middle East & Africa Onychomycosis Forecast by Region (2025-2030)
10.5.1 Egypt Onychomycosis Market Forecast
10.5.2 South Africa Onychomycosis Market Forecast
10.5.3 Israel Onychomycosis Market Forecast
10.5.4 Turkey Onychomycosis Market Forecast
10.5.5 GCC Countries Onychomycosis Market Forecast
10.6 Global Onychomycosis Forecast by Type (2025-2030)
10.7 Global Onychomycosis Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Onychomycosis Product Offered
11.1.3 Abbott Laboratories Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Information
11.2.2 Glaxosmithkline Onychomycosis Product Offered
11.2.3 Glaxosmithkline Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Glaxosmithkline Main Business Overview
11.2.5 Glaxosmithkline Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Onychomycosis Product Offered
11.3.3 Pfizer Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bausch Health
11.4.1 Bausch Health Company Information
11.4.2 Bausch Health Onychomycosis Product Offered
11.4.3 Bausch Health Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bausch Health Main Business Overview
11.4.5 Bausch Health Latest Developments
11.5 Galderma
11.5.1 Galderma Company Information
11.5.2 Galderma Onychomycosis Product Offered
11.5.3 Galderma Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Galderma Main Business Overview
11.5.5 Galderma Latest Developments
11.6 Janssen Biotech
11.6.1 Janssen Biotech Company Information
11.6.2 Janssen Biotech Onychomycosis Product Offered
11.6.3 Janssen Biotech Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Janssen Biotech Main Business Overview
11.6.5 Janssen Biotech Latest Developments
11.7 Bristol Meyer Squibb
11.7.1 Bristol Meyer Squibb Company Information
11.7.2 Bristol Meyer Squibb Onychomycosis Product Offered
11.7.3 Bristol Meyer Squibb Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bristol Meyer Squibb Main Business Overview
11.7.5 Bristol Meyer Squibb Latest Developments
11.8 Topica Pharmaceuticals
11.8.1 Topica Pharmaceuticals Company Information
11.8.2 Topica Pharmaceuticals Onychomycosis Product Offered
11.8.3 Topica Pharmaceuticals Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Topica Pharmaceuticals Main Business Overview
11.8.5 Topica Pharmaceuticals Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Onychomycosis Product Offered
11.9.3 Sanofi Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Onychomycosis Product Offered
11.10.3 Novartis Onychomycosis Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Novartis Main Business Overview
11.10.5 Novartis Latest Developments
12 Research Findings and Conclusion






